[Bioavailability of cyproterone acetate after oral and intramuscular application in men (author's transl)].
Cyproterone acetate was administered orally and intramuscularly to 5 male patients. The level of the active substance in plasma was monitored at intervals during the period of application using radioimmunoassay specific for cyproterone acetate. The areas under the drug level curves were similar after oral and intramuscular application of cyproterone acetate when taking into consideration the different doses used. Accordingly, cyproterone acetate is not dependent upon a "first-pass" effect. The bioavailability of the active substance was complete following oral application.
D000284:Administration, Oral; D000368:Aged; D001682:Biological Availability; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood; D017373:Cyproterone Acetate; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D011863:Radioimmunoassay
D017373:Cyproterone Acetate; D003534:Cyproterone
Bioverfügbarkeit von Cyproteronacetat nach oraler und intramuskulärer Applikation bei Männern.